EXEMESTANE 25MG X 45 TABLETS – HIKMA

EXEMESTANE 25MG X 45 TABLETS – HIKMA RESEARCH COMPOUND

Exemestane 25mg is a steroidal aromatase inhibitor produced by Hikma Laboratories, formulated for laboratory research into estrogen biosynthesis inhibition, hormonal regulation, and endocrine signaling pathways. It functions as an irreversible aromatase inactivator, providing researchers a precise model to study the suppression of estrogen formation from androgens in cellular and biochemical systems.

Researchers utilize Exemestane in controlled environments to explore hormonal balance, enzyme kinetics, and the downstream effects of aromatase modulation. Its structure and mechanism make it suitable for comparative studies alongside non-steroidal aromatase inhibitors and selective estrogen receptor modulators (SERMs).

The Details:

• Dosage: 25mg per tablet

• Quantity: 45 tablets per container

• Form: Oral research tablets

• Packaging: Sealed, tamper-proof container for product stability

• Source: Manufactured by Hikma Laboratories under strict quality and purity standards

• Purity: ≥99% verified by HPLC and mass spectrometry

Key Features of Exemestane:

• Aromatase Inactivation: Irreversible suppression of estrogen synthesis for endocrine pathway modeling.

• Enzymatic Pathway Research: Supports analysis of CYP19A1 enzyme kinetics and feedback regulation.

• Hormonal Regulation Studies: Enables evaluation of estrogen/androgen balance in tissue models.

• Comparative Inhibitor Analysis: Useful for contrasting steroidal and non-steroidal aromatase inhibitors.

• Hikma Manufacturing Quality: Laboratory-produced and independently verified for purity and potency.

For more products, visit: https://www.canadasteroiddepot.is/